Advertisement

Hormones

, Volume 14, Issue 1, pp 167–171 | Cite as

The philosopher Socrates had exophthalmos (a term coined by Plato) and probably Graves’ disease

  • Peter D. Papapetrou
Letter to the editor

Abstract

According to a previously published theory, Socrates was afflicted with temporal lobe epilepsy since his childhood. Plato, Xenophon, and Aristoxenus described Socrates as having exophthalmos, probably diplopia, and some symptoms compatible with hyperthyroidism. Using these data, we theorize that Socrates had Graves’ disease. In order to determine a cause of his temporal lobe epilepsy, we speculate that the philosopher also had autoimmune thyroiditis and Hashimoto encephalopathy during his childhood and his epilepsy may have been a sequel to this hypothesized encephalopathy.

Key words

Exophthalmos Graves’ disease Hashimoto encephalopathy Socrates 

References

  1. 1.
    Muramoto O, Englert WG, 2006 Socrates and Temporal Lobe Epilepsy: A Pathographic Diagnosis 2,400 Years Later. Epilepsia 47: 652–654.CrossRefGoogle Scholar
  2. 2.
    Plato 1914 Volume I (Euthyphro, Apology, Crito, Phaedo, Phaedrus). Translated by H.N. Fowler. Loeb Classical Library, Harvard University Press, Cambridge Mass.Google Scholar
  3. 3.
    Guthrie WKC 1971 Socrates. Cambridge University Press; pp, 66.Google Scholar
  4. 4.
    Nails Debra 2014 “Socrates”. The Stanford Encyclopedia of Philosophy (Spring 2014 Edition), Edward N. Zalta (ed).Google Scholar
  5. 5.
    Alper MG, Wartofsky L 2001 Endocrine ophthalmopathy. In Principles and Practice Endocrinology and Metabolism. K. L. Becker (ed) Lippincott Williams & Wilkins publishers, Philadelphia, PA; pp, 428.Google Scholar
  6. 6.
    Aristoxenus’ life of Socrates 2012. In Aristoxenus of Tarentum Discussion. Rutgers University Studies in Classical Humanities, Volume XVII, Carl A. Hoffman (ed) New Brunswick, N.J. Transaction PublishersGoogle Scholar
  7. 7.
    Ugarte G, Peresa T, 1978 Influence of hyperthyroidism on the rate of ethanol metabolism in man. Nutr Metab 22: 113–118.CrossRefGoogle Scholar
  8. 8.
    Armanghue T, Petit-Pedrol M, Dalmau J, 2012 Autoimmune encephalitis in children. J Clild Neurol 27: 1460–1469.CrossRefGoogle Scholar
  9. 9.
    Vasconcellos E, Pina-Garza JE, Fakhoury T, Fenichel GM, 1999 Pediatric manifestations of Hashimoto’s encephalopathy. Pediatr Neurol 20: 394–398.CrossRefGoogle Scholar
  10. 10.
    Mahmud FH, Lteif AN, Renaud DL, Reed AM, Brands CK, 2003 Steroid-responsive encephalopathy associated with Hashimoto’s thyroiditis in an adolescent with chronic hallucinations and depression: case report and review. Pediatrics 112: 686–690.CrossRefGoogle Scholar
  11. 11.
    Devinsky O, Schein A, Najjar S, 2013 Epilepsy associated with systemic autoimmune disorders. Epilepsy Currents 13: 62–68.CrossRefPubMedPubMedCentralGoogle Scholar
  12. 12.
    Tsai MH, Lee LH, Chen SD, Lu CH, Chen MT, Chuang YC, 2007 Complex partial status epilepticus as a manifestation of Hashimoto’s encephalopathy. Seizure 16: 713–716.CrossRefGoogle Scholar
  13. 13.
    Chong JY, Rowland LP, Utiger RD, 2003 Hashimoto encephalopathy. Syndrome or myth? Arch Neurol 60: 164–171.CrossRefGoogle Scholar
  14. 14.
    Rallison ML, Dobyns BM, Keating FR, Rall JE, Tyler FH, 1975 Occurrence and natural history of chronic lymphocytic thyroiditis in childhood. J Pediatr 86: 675–682.CrossRefGoogle Scholar
  15. 15.
    McLarty DG, Beownlie BEW, Alexander WD, Papapetrou PD, Horton P, 1973 Remission of Thyrotoxicosis during Treatment with Propranolol. BMJ 2: 332–334.CrossRefGoogle Scholar
  16. 16.
    Codaccioni JL, Orgiazzi J, Blanc P, Pugeat M, Roulier R, Carayon P, 1988 Lasting remissions in patients treated for Graves’ hyperthyroidism with propranolol alone: a pattern of spontaneous evolution of the disease. J Clin Endocrinol Metab 67: 656–662.CrossRefGoogle Scholar

Copyright information

© Hellenic Endocrine Society 2015

Authors and Affiliations

  1. 1.Papagou, AthensGreece

Personalised recommendations